Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA information technology

Executive Summary

FDA Information Technology Program Director Fred Farmer will become acting chief information officer Aug. 1 until a permanent replacement is found for departing CIO Jim Rinaldi. Rinaldi has accepted the CIO position with NASA's Jet Propulsion Laboratory; he became FDA's CIO in December 2002 ( 1"The Pink Sheet" Jan. 13, 2003, In Brief)...

You may also be interested in...

FDA acting CIO to depart

FDA Acting Chief Information Officer Fred Farmer is leaving to return to a career in the private sector, effective July 22. Farmer assumed the role of acting CIO following the departure of CIO Jim Rinaldi last year (1"The Pink Sheet" Aug. 1, 2005, In Brief). FDA Associate Commissioner for Management and CFO Kathleen Heuer will assume the role of acting CIO as the agency completes its search for a permanent replacement...

FDA names top technology staffer

FDA Chief Information Officer Jim Rinaldi appointed Dec. 29, following five-month stint leading the agency's IT consolidation. Rinaldi joined FDA from the Internal Revenue Service...

Robust Trial Transparency Strategy Boosts Patient Engagement

Most clinical trial sponsors view data disclosure as a mandate, maintaining regulatory compliance as a legal requirement. Study sponsors that realize the potential to repurpose this data, using a patient-first approach, turn transparency into a strategic advantage for engagement and recruitment efforts.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts